Broodman I., VanDuijn M.M., Stingl C., Dekker L.J.M., Germenis A.E., De Koning H.J., Van Klaveren R.J., Aerts J.G., Lindemans J., Luider T.M. (2016)
The high mortality rate in lung cancer is largely attributable to late diagnosis. Case-control studies suggest that autoantibodies to the survivin protein are potential biomarkers for early diagnosis. We tested the hypothesis ...